Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Taro Pharm Inds (TARO)

107.89 +2.32 (+2.20%)

10/19/2017  4:02pm

Open:

105.78

Pre. Close:

105.57

High:

108.16

Low:

105.50

Volume:

55,675

Market Cap:

4.37B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

108.4 - 109.24

109.24 - 110.36

Low:

103.88 - 104.08

104.08 - 104.35

Close:

107.07 - 108.02

108.02 - 109.26

Technical analysis  (as of: 2017-10-19 4:38:54 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 129.75     One year: 134.36

Support:

Support1: 104.70    Support2: 87.11

Resistance:

Resistance1: 111.08    Resistance2: 115.03

Pivot:

111.26

Moving Averages:

MA(5): 108.06     MA(20): 111.13

MA(100): 109.49     MA(250): 109.55

MACD:

MACD(12,26): 0.04     Signal(12,26,9): 0.91

%K %D:

%K(14,3): 19.33     %D(3): 14.87

RSI:

RSI(14): 44.89

52-Week:

High: 124.52  Low: 92.28  Change(%): 3.8

Average Vol(K):

3-Month: 9699  10-Days 2634

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
TARO has closed above bottom band by 18.3%. Bollinger Bands are 3.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 13 Jun 2017 14:56:07 GMT
Taro Pharmaceuticals: Positioning To Negotiate With Dilip Shanghvi

Fri, 04 Aug 2017 21:45:00 GMT
Taro Pharmaceutical: Solid Cash-Rich Business With No Debt And A Catalyst

Fri, 09 Jun 2017 06:20:15 GMT
The Long Case For Taro Pharmaceutical

Tue, 23 May 2017 18:22:30 GMT
Taro Pharmaceutical Industries' (TARO) Interim CEO Abhay Gandhi on Q4 2017 ...

Thu, 23 Mar 2017 14:03:45 GMT
Taro Pharmaceutical: Upside Potential With Limited Downside Risk

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

40.00

Shares Float (M)

11.01

% Held by Insiders

72.81

% Held by Institutions

15.64

Shares Short (K)

1790

Shares Short Prior Month (K)

2140

Stock Financials

EPS

9.820

EPS Est. Current Year

9.490

EPS Est. Next Year

7.990

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

52.840

PEG Ratio

Profit Margin

49.69

Operating Margin

55.78

Return on Assets (ttm)

12.4

Return on Equity (ttm)

19.8

Qtrly Rev. Growth

-31.0

Gross Profit (p.s.)

16.588

Sales Per Share

20.173

EBITDA (p.s.)

11.626

Qtrly Earnings Growth

-50.40

Operating Cash Flow (M)

454.24

Levered Free Cash Flow (M)

446.49

FoxReading.com

Valuation

P/E

10.99

P/E Growth Ratio

0.02

P/BV

2.04

P/S

5.35

P/CF

9.50

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.